Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...
Disclaimer: When you purchase through links on our site, we may earn an affiliate commission. It's time to learn everything you need to know about HBO Max, one of the most popular streaming services ...
The past few years have been a confusing time for HBO Max, and more importantly, anyone who wants to subscribe to it. From being called HBO Max back in 2020 to going with Max a few years later and ...
If you’ve been shocked by how much you spend on streaming services lately, you’re not alone. Companies like Netflix, Disney, HBO Max and others have been consistently raising prices to the point where ...
Max is officially back to being HBO Max. Even though the name has changed (returned?), the library is still full of great films and shows to watch. HBO Max is home to some incredibly high-quality ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
This article is updated frequently as titles leave and enter HBO Max. *New additions are indicated with an asterisk. You’ll find our selections organized into five genre categories — drama, action, ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback